Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 777 of 6351
-
Smartphone app aims to combat malnutrition in head and neck cancer patients
Disease control Recruiting nowPatients with head and neck cancer requiring definitive or adjuvant radio(chemo)therapy can take part in the study. The aim is to record the nutritional status and diet of the patients during the trial and regularly at a period of 8 weeks after irradiation and to reduce the rate …
Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New shot offers hope for Tough-to-Treat eczema
Disease control OngoingThis is a parallel group, Phase 3, multinational, multicenter, randomized, double-blind, placebo-controlled, 3-arm study for treatment of participants diagnosed with moderate-to-severe AD on background TCS who have had inadequate response to prior biologic or oral JAKi therapy. …
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New drug combo targets tough prostate cancer
Disease control Recruiting nowTo find the best dose of ADI-PEG20 that can be given in combination with carboplatin and cabazitaxel to patients with AVPC.
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Gene therapy trial targets rare heart disease in 10 patients
Disease control OngoingThis is a Phase 1/2, first-in-human, open-label, intravenous, dose-escalating, multicenter trial that is designed to assess the safety and tolerability of LX2020 in adult patients with PKP2-ACM
Phase 1/2 • Sponsor: Lexeo Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New hope for lung cancer patients: drug combo targets tumors after treatment failure
Disease control Recruiting nowTo access the anti-tumor efficacy, safety and tolerability of Sunvozertinib combined with chemotherapy in patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) sensitizing mutations who have progressed fo…
Phase 1/2 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Can freezing a nerve silence the 'Suicide Disease'?
Symptom relief OngoingThe CryoGem Trial is a research study that tests a freezing technique called cryoneurolysis to see if it helps relieve pain in adults with trigeminal neuralgia. Trigeminal neuralgia is a condition that causes severe facial pain. In this study, we want to find out if the freezing …
Sponsor: St. Olavs Hospital • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Asthma breakthrough? new study tests cutting back on meds with benralizumab
Disease control CompletedThis is a prospective, multi-center, single-arm Phase 3b study designed to evaluate the potential benefit to patients if benralizumab treatment could enable reduction in asthma maintenance controllers while allowing patients to maintain asthma control in Chinese patients.
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could a simple pill replace infusions for aHUS patients?
Disease control Recruiting nowThe purpose of this Phase 3 study is to evaluate the efficacy and safety of iptacopan upon switching from anti-C5 antibody to iptacopan treatment in study participants with aHUS.
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New combo aims to stop early breast cancer in its tracks
Disease control Recruiting nowThe purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on invasive breast cancer-free survival (iBCFS), in a close to clinical practice pati…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 10, 2026 01:00 UTC
-
New heart catheter shows promise for stopping AFib episodes
Disease control CompletedThe purpose of this study is to demonstrate safety and effectiveness of the Biosense Webster (BWI) ablation system (THERMOCOOL SMARTTOUCH surround flow \[STSF\] catheter and TRUPULSE generator) when used for isolation of the atrial pulmonary veins (PVs) in treatment of participan…
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Machine breathes new life into fatty livers for transplant
Disease control Recruiting nowThe goal of this clinical trial is to assess the ability of Normothermic Machine Perfusion (NMP) to resuscitate moderately steatotic livers for transplantation in patients. This will be a single-site clinical trial placing donor livers with 30-60% macrosteatosis on NMP, and then …
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can we decode the hidden subtypes of early Parkinson's?
Knowledge-focused Recruiting nowYoung Onset Parkinson's disease (YOPD) refers to a group of patients in which the disease starts earlier in life (before the age of 50 years) and has a profound impact on most of patient's life. Current knowledge regarding the mechanisms leading to development of Parkinson's dise…
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
New drug verekitug aims to curb severe asthma attacks
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will evaluate the incidence of asthma exacerbations, other pharmacodynamic (PD) parameters such as lung function and asthma control, and the safet…
Phase 2 • Sponsor: Upstream Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Chemo-loaded microspheres aim to starve liver tumors from within
Disease control Recruiting nowThe primary objective of the study is to confirm safety and technical success of BioPearl™ microspheres loaded with Doxorubicin in the treatment of unresectable hepatocellular carcinoma (HCC). The secondary objective of the study is to investigate the efficacy of BioPearl™ micros…
Sponsor: Terumo Europe N.V. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
School health rooms and trained teachers: a new hope for Zambia's children?
Prevention OngoingIn Zambia, the health and well-being of children aged 5 to 14 has often been overlooked, leading to various health challenges affecting their development and education. The Healthy Learners (HL) program, in collaboration with the Zambian Government, aims to address this gap by im…
Sponsor: London School of Economics and Political Science • Aim: Prevention
Last updated Aug 29, 2026 00:00 UTC
-
New pill plus chemo shows promise for Hard-to-Treat colon cancer
Disease control OngoingThe purpose of this study is to assess 2 different doses of onvansertib to select the lowest dose that is maximally effective, and to assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of onvansertib in combination with FOLFIRI + bevacizumab or FOLFOX + bevacizum…
Phase 2 • Sponsor: Cardiff Oncology • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
AI-Powered wristband aims to quiet essential tremor without drugs
Symptom relief CompletedThe goal of this clinical study is to compare Felix NeuroAI Wristband and sham device in patients with essential tremor. The main question it aims to answer is: • Is Felix a safe and efficacious treatment for patients with essential tremor? Participants will be treated with eit…
Sponsor: Fasikl Inc. • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
New pill could stop swelling attacks in hereditary angioedema
Disease control CompletedThis is a Phase 3, multicenter, randomized, double-blind, placebo-controlled, 2-period, 2-treatment cross-over study to evaluate the efficacy and safety of orally administered deucrictibant compared to placebo for the on-demand treatment of HAE attacks, including non-severe laryn…
Phase 3 • Sponsor: Pharvaris Netherlands B.V. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a kidney drug for type 2 diabetes also help type 1 patients?
Disease control CompletedResearchers are looking for a better way to treat people with chronic kidney disease (CKD), a progressive decrease in the kidneys' ability to work properly, and type 1 diabetes. In people with type 1 diabetes, the body does not make enough of a hormone called insulin, resulting …
Phase 3 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New hope for advanced anal cancer: chemo before radiation may boost survival
Disease control Recruiting nowSquamous cell carcinoma of the anus is still a rare disease but its incidence increases mostly due to its association with human papillomavirus (HPV). When localized, the standard treatment combines radiotherapy and chemotherapy with 5FU and mitomycin-C. Chemoradiotherapy (CRT) a…
Phase 3 • Sponsor: Federation Francophone de Cancerologie Digestive • Aim: Disease control
Last updated Jun 26, 2026 12:50 UTC